日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TBC1D23 drives lymphatic metastasis in pancreatic ductal adenocarcinoma by altering EGFR cell surface dynamics and signaling

TBC1D23通过改变EGFR细胞表面动力学和信号传导驱动胰腺导管腺癌的淋巴转移

Chao, Ying-Jui; Wang, Hao-Chen; Chen, Yu-Lun; Wang, Chih-Jung; Hou, Ya-Chin; Kuo, Yu-Ting; Shin, Jyh-Wei; Shan, Yan-Shen

Macrophage activation determines muscle wasting in pancreatic cancer.

胰腺癌中巨噬细胞活化导致肌肉萎缩

Chang Chia-Jung, Huang Po-Hsien, Chen Szu-Ying, Su Pei-Chia, Ding Li-Yun, Hou Ya-Chin, Hung Miao-Neng, Chen Kuan-Lin, Wu Ya-Na, Wu Shang-Rung, Lin Forn-Chia, Lu Pei-Jung, Wu Hsin-Yi, Chen Yu-Ju, Chang Chih-Han, Chang Chih-Peng, Hwang Daw-Yang, Wang Yi-Ching, Shan Yan-Shen

Arid1a deficiency sensitises pancreatic cancer to fatty acid synthase inhibition.

Arid1a 缺乏症使胰腺癌对脂肪酸合成酶抑制剂更加敏感

Kuo Tzu-Lei, Hou Ya-Chin, Shan Yan-Shen, Chen Li-Tzong, Hung Wen-Chun

CD204-positive M2-like tumor-associated macrophages increase migration of gastric cancer cells by upregulating miR-210 to reduce NTN4 expression

CD204阳性的M2样肿瘤相关巨噬细胞通过上调miR-210降低NTN4表达,从而促进胃癌细胞的迁移。

Chen, Chin-Wang; Wang, Hao-Chen; Tsai, I-Min; Chen, I-Shu; Chen, Chang-Jung; Hou, Ya-Chin; Shan, Yan-Shen

New insights into the role of adipocytes in pancreatic cancer progression: paving the way towards novel therapeutic targets

脂肪细胞在胰腺癌进展中的作用新见解:为新型治疗靶点的发现铺平道路

Lin, Yu-Chun; Hou, Ya-Chin; Wang, Hao-Chen; Shan, Yan-Shen

Pancreatic stellate cells activated by mutant KRAS-mediated PAI-1 upregulation foster pancreatic cancer progression via IL-8

突变型KRAS介导的PAI-1上调激活胰腺星状细胞,并通过IL-8促进胰腺癌进展。

Wang, Hao-Chen; Lin, Yung-Lun; Hsu, Ching-Cheng; Chao, Ying-Jui; Hou, Ya-Chin; Chiu, Tai-Jan; Huang, Po-Hsien; Tang, Ming-Jer; Chen, Li-Tzong; Shan, Yan-Shen